Brief: Nanorepro announces exclusive five-year contract with Global Pharma Serbia
05/11/2015 08:18
Nov 5 (Reuters) - Nanorepro AG NN6G.DE :
* Global Pharma Serbia will sell the products in the target countries in the name of
Nanorepro
* Announces exclusive five-year contract with Global Pharma Serbia for eleven rapid tests
* Contract has a term of five years and is valid for eleven rapid tests in the fields of
family planning, health care and food intolerances
Source text for Eikon: ID:nEQbyhSpqa
Further company coverage: NN6G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on NanoRepro AG
See all newsBrief: NanoRepro Enters Market For Diabetes Diagnostics
Brief: NanoRepro FY Profit After Taxes At EUR 29.7 Mln
Brief: Nanorepro Announces Talks With Viromed Group On Integration Of Individual Business Units Terminated For The Time Being
Brief: NanoRepro Completes Comparative Study, Says Its Tests Detect Omicron
Brief: NanoRepro - Change In Forecast 2021 And Outlook 2022 With Dividend